ArmeoSenso - Home Therapy and Assessment for Patients With Arm Impairments Based on Wearable Movement Sensors

Phase 1 Study of a Home Therapy and Assessment for Patients With Arm Impairments

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02098135

Enrollment

Registered

2014-03-27

Start date

2013-11-30

Completion date

2015-09-30

Last updated

2015-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke, Spinal Cord Injury

Brief summary

stroke, spinal cord injury, rehabilitation, home therapy, upper limb, arm, virtual reality, interia sensor, * Trial with medical device

Interventions

DEVICEArmeoSenso

Virtual realty therapy with a touchscreen computer and movement sensors, over 42 days.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* 18 years old * Stroke or spinal cord injury in prehistory * Motor deficits of the upper limb (s) * Lifting the paretic arm against gravity possible AND * Minimum amount of movement in the horizontal plane of 20 x 20 cm * Ability and willingness to participate in the study

Exclusion criteria

* Severe aphasia * Severe dementia * Severe depression * Relevant restriction of vision, which can not be compensated by aids (eg hemianopia)

Design outcomes

Primary

Measure	Time frame
Numbers of participant which can perform the ArmeoSenso - training.	42 days

Secondary

Measure	Time frame	Description
Improvement in the Arm function	42 days	WMFT (Wolf Motor Function Test), FMA-UL (Fugl-Meyer Assessment - Upper Limb), GRASSP (Graded and Redefined Assessment of Strength, Sensibility and Prehension)

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 12, 2026